Research highlights patients’ perspective in management of chronic pain

26 January 2007

GPs should consider opioid medication for patients with chronic non-cancer pain, according to a patient study published in this month’s British Journal of General Practice.

 

A strong GP-patient relationship and the importance of coping strategies in the long term management of pain are also highlighted in the research, which was initiated by a patient at the Honiton Research Practice in East Devon.

 

Based on the views of a patient focus group and interviews with individuals at the Honiton practice, the study examined the attitudes and experiences of those receiving long-term medication for chronic non-cancer pain in primary care.

 

All had been using opioid medication for between 8-108 months (a median of 15-28 months). They were asked about the type of pain they suffered; the duration and impact of the pain on their lives and relationships; and their experiences of using strong opioid analgesia.

 

Despite evidence-based guidelines for the appropriate use of strong opioids*, doubts have been expressed about their use for chronic non-cancer pain with concern focusing on problems such as intolerance and addiction.

 

In addition, little work has been done about the experiences of patients receiving these drugs in a primary care setting.

 

Attitudes to opioid medication were both positive and negative. Concerns about intolerance and fears of addiction were tempered with an appreciation of the medication dramatically decreasing their pain and allowing them to lead a nearer-to-normal existence.

 

All patients described coping strategies they had developed themselves or had learned from outside influences, such as pain clinic courses and support from their GP. They realised that total pain relief was not possible, but that a workable balance could be struck between levels of pain relief and possible side effects such as sedation and nausea.

 

The study concluded patients in the study appreciated the benefits of strong opioid medication, having adopted coping strategies and overcome fears of addiction.

Study author Dr David Seamark says: “The prevalence of chronic pain is likely to increase with an ageing population and the use of strong opioid medication in primary care may increase.

 

“There is a need for further studies examining the potential barriers to initiating prescribing of strong opioids by GPs and the degree of confidence and comfort they have in monitoring patients receiving long-term opioids for chronic pain.”

 

Ends

For more information please contact Lorna Fletcher, RCGP Press Office, 020 7344 3136 / lfletcher@rcgp.org.uk

NOTES TO EDITORS

  • Experiences of patients requiring strong opioid drugs for chronic non-cancer pain: a patient-initiated study is authored by  Sue Blake, Brian Ruel, Dr Clare Seamark and Dr David Seamark of The Honiton Group Practice, Honiton
  • *Kalso E, Allan L, Dellemijn PLI et al. Recommendations for using opioids in chronic non-cancer pain (Eur J Pain 2003)

British Pain Society. Recommendations for the appropriate use of opioids for persistent non-cancer pain (2006)

 

If you encounter a problem with this page please email the web team
© Royal College of General Practitioners 2008
Registered Charity Number - 223106